Tumor microenvironment cells also concur to anti-cancer immune escape through the expression of inhibitor receptors on cancer and immune surface, such as the programmed death-ligand 1 and 2 (PD-L1, PD-L2) and the CTLA-4. Here, CD274 is linked to neoplasm.